Who are diabetic foot patients? A descriptive study on 873 patients

Journal of Diabetes & Metabolic Disorders

Mohammad-Reza Mohajeri-Tehrani¹  Bagher Larijani²  Ramin Heshmat²  Mohammad Pajouhi²  Ozra Tabatabaei-Malazy²  Nima Madanchi² 

[1] Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Shariati Hospital, North Kargar Street, 14114, Tehran, Iran;Endocrinology and Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran

关键词: Patient care;    Ulcer;    Diabetic foot;    Diabetes mellitus;   

Others  :  806906
DOI  :  10.1186/2251-6581-12-36

 received in 2012-10-14, accepted in 2013-06-26,  发布年份 2013

【 摘 要 】

Background

Diabetic foot ulcer (DFU) as the leading cause of lower limb amputation is one of the most important complications of diabetes mellitus (DM). Patient and physician’s education plays a significant role in DFU prevention. While effective treatment and formulation of prevention guidelines for DFU require a thorough understanding of characteristics of DFU patients and their ulcers, there are reports that not only patients’ but also physicians’ information about these characteristics is inadequate. So we conducted this study to investigate these characteristics.

Methods

Necessary data was collected from medical archives of DFU patients admitted between 2002 and 2008 in two university hospitals.

Results

873 patients were included. Mean age was 59.3 ± 11.2 years and most of the patients developed DFU in 5th and 6th decades of their life. 58.1% were men. 28.8% had family history of DM. Mean duration of DM was 172.2 months. Mean duration of DFU was 79.8 days. Only 14.4% of the patients had Hemoglobin A1C < 7%. 69.6% of the patients had history of previous hospitalization due to DM complications. The most prevalent co-morbidities were renal, cardiovascular and ophthalmic ones. Most patients had “ischemic DFU” and DFU in their “right” limb. The most prevalent location of DFU was patients’ toes, with most of them being in the big toe. 28.2% of the patients underwent lower-limb amputations. The amputation rate in the hospital where the “multidisciplinary approach” has been used was lower (23.7% vs. 30.1%).

Conclusions

Number of patients with DFU is increasing. DFU is most likely to develop in middle-aged diabetic patients with a long duration of DM and poor blood sugar control who have other co-morbidities of DM. Male patients are at more risk. Recurrence of DFU is a major point of concern which underscores the importance of patient education to prevent secondary ulcers. As a result, educating medical and nursing personnel, applying screening and prevention guidelines, and allocating more resources are of great importance regarding treatment of DFU patients. Application of the “multidisciplinary approach” can reduce the rate of amputations. Primary care physicians might be furnished with the information presented in the present study.

【 授权许可】

   
2013 Madanchi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Boulton AJ: The pathogenesis of diabetic foot problems: an overview. Diabetes Med 1996, 13:12-16.
• [2]Wieman TJ: Principles of management: the diabetic foot. Am J Surg 2005, 190:215-229.
• [3]Reiber GE, Vileikyte L, Boyko EJ, Del Aguila M, Smith DG, Lavery LA, Boulton AIM: Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999, 22:157-162.
• [4]Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of neuropathy and high foot pressure in diabetic foot ulceration. Diabetes Care 1998, 21:1714-1719.
• [5]Reiber GE: The epidemiology of foot ulcers and amputations in the diabetic foot. In Levin and o’Neal’s The Diabetic Foot. 6th edition. Edited by Bowker JH, Pfeiter MA. St Louis: Mosby; 2001:13-32.
• [6]Reiber GE, Lipsky BA, Gibbons GW: The burden of diabetic foot ulcers. Am J Surg 1998, 176:5-10.
• [7]Most RS, Sinnock P: The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983, 6:87-91.
• [8]Calle-Pascual AL, Redondo MJ, Ballesteros M, Martinez-Salinas MA, Diaz JA, De Matias P, Calle JR, Gil E, Jimenez M, Serrano FJ, Martin-Alvarez PJ, Maranes JP: Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid Spain. Diabetes Metab 1997, 23:519-523.
• [9]Adler AI, Boyko EJ, Ahroni EH, Smith DG: Lower-extremity amputation in diabetes: The independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care 1999, 22:1029-1035.
• [10]Ramachandran A: Specific problems of the diabetic foot in developing countries. Diabetes Metab Res Rev 2004, 20(suppl 1):S19-S22.
• [11]Van Houtum WH, Lavery LA, Harkless LB: The impact of diabetes-related Lower extremity amputations in the Netherlands. J Diabetes Complications 1996, 10:325-330.
• [12]Bakker K, Riley PH: The year of the diabetic foot. Diabetes Voice 2005, 50:11-14.
• [13]Levin ME: Pathophisiology of diabetic foot lesions. In Clinical Diabetes Medicine. Edited by Davidson JK. St Louis: Mosby; 1991:504-520.
• [14]Boyko EJ, Ahroni JH, Smith DG, Davignon D: Increased mortality associated with diabetic foot ulcer. Diabetic Med 1996, 13:967-972.
• [15]Pliskin MA, Todd WF, Edelson GW: Presentations of diabetic feet. Arch Fam Med 1994, 3:273-279.
• [16]Gibbons GW: The diabetic foot: amputations and drainage of infection. J Vasc Surg 1987, 5:791-793.
• [17]Abolhasani MR, Mohajeri Tehrani O, Tabatabaei Malazy F, Larijani B: Burden of diabetes and its complications in Iran in the year 2000. IJDL 2005, 5:35-48.
• [18]Goodridge D, Trepman E, Embil JM: Health-related quality of life in diabetic patients with foot ulcers: literature review. J Wound Ostomy Cont Nurs 2005, 32:368-377.
• [19]Ragnarson-Tennvall G, Apelqvist J: Prevention of diabetes related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001, 44:2077-2087.
• [20]Larvey LA, Wunderlichn RP, Tredwell JL: Disease management for diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005, 70:31-37.
• [21]Wylie Rosett J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P: Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med 1995, 4:46-50.
• [22]Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
• [23]Larijani B, Afshari M, Darvishzadeh F, Bastanhagh MH, Pajouhi M, Baradar Jaili R, Moadi M: Lower limb amputation in patients with diabetic foot ulcer: a 22 year review. MJIRC 2006, 8:21-24.
• [24]Nathera A, Siok Beeb C, Yiong Huakc C, Chewa JLL, Lina CB, Neoa Sh CB, Sima EY: Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complications 2008, 22:77-82.
• [25]Widatalla AH, Mahadi SI, Shawer MA, Elsayem HA, Ahmed ME: Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diab Dev Ctries 2009, 29:1-5.
• [26]Shojaiefard A, Khorgami Z, Larijani B: Independent risk factors for amputation in diabetic foot. Int J Diab Dev Ctries 2008, 28:32-37.
• [27]Bose K: Infection in diabetic foot. Ann Acad Med Singapore 1978, 7:359-365.
• [28]Shojaie Fard A, Esmaelzadeh M, Larijani B: Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 2007, 61:1931-1938.
• [29]Miyajima S, Shirai A, Yamamoto S, Okada N, Matsushita T: Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006, 71:272-279.
• [30]Dos Santos VP, da Silveira DR, Caffaro RA: Risk factors for primary major amputation in diabetic patients. Sao Paulo Med J 2006, 124:66-70.
• [31]Moss SE, Klein R, Klein BE: The prevalence and incidence of lower extremity amputation in diabetic population. Arch Intern Med 1992, 152:610-616.
• [32]Apelqvist S, Larsson J, Agardh CD: Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993, 233:485-491.
• [33]Murray HJ, Young MJ, Hollis S, Boulton AJ: The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet Med 1996, 13:979-982.
• [34]Goldner MG: The fate of the second leg in the diabetic amputee. Diabetes 1960, 9:100-103.
• [35]Consensus Development Conference on Diabetic Foot Wound Care: ADA. Diabetes care 1999, 22:1354-1360.
• [36]Boulton AJM, Vileikyte L: The diabetic foot: the scope of the problem. J Fam Pract 2000, 49(Suppl):S3-S8.
• [37]Apelquist J, Larsson J: What is the most effective way to reduce the incidence of amputation in the diabetic foot? Diabetes Metab Res 2000, 16(Suppl):75-83.
• [38]Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE: Incidence, outcome and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382-387.